Because SABRIL might cause permanent vision loss, it is available to healthcare providers and patients only under a special program called the Vigabatrin Risk Evaluation and Mitigation Strategy (REMS) Program. Your healthcare provider will explain the details of this program to you. SABRIL can damage the vision of anyone who takes it.

Before starting SABRIL, tell your doctor about all of your (or your child’s) medical conditions including depression, mood problems, suicidal thoughts or behavior, any allergic reaction to SABRIL, vision problems, kidney problems, low red blood cell counts (anemia), and any nervous or mental illness.

2017年2月16日 · Before starting SABRIL, tell your doctor about all of your (or your child’s) medical conditions including depression, mood problems, suicidal thoughts or behavior, any allergic reaction to SABRIL, vision problems, kidney problems, low red blood cell counts (anemia), and any nervous or mental illness.

Because SABRIL might cause permanent vision loss, it is available to healthcare providers and patients only under a special program called the Vigabatrin Risk Evaluation and Mitigation Strategy (REMS) Program. Your healthcare provider will explain the details of this program to you. SABRIL can damage the vision of anyone who takes it.

Click the links below for access to the Sabril Prescription Form or access to the Complete Terms and Conditions for the Sabril patient support programs that may be available for eligible, commercially insured patients.

Because SABRIL might cause permanent vision loss, it is available to healthcare providers and patients only under a special program called the Vigabatrin Risk Evaluation and Mitigation Strategy (REMS) Program. Your healthcare provider will explain the details of this program to you. SABRIL can damage the vision of anyone who takes it.

SABRIL (vigabatrin) for Oral Solution is back in stock. Please speak to your healthcare provider about your specific situation and how this may affect you. The StarterRx program for the Oral Solution is again available for eligible commercially insured patients.

SABRIL (vigabatrin) is indicated as adjunctive therapy for patients 2 years of age and older with refractory complex partial seizures (CPS) who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss. SABRIL is not indicated as a first line agent for CPS.

SABRIL (vigabatrin) is indicated as adjunctive therapy for patients 2 years of age and older with refractory complex partial seizures (CPS) who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss.

Patients are eligible for Informational Support if they have a valid prescription for Sabril and a request is submitted to the SHARE. Plus. Coordinating Center using a completed Sabril Prescription Form. Informational Support includes insurance coverage information related to Sabril and, depending on patient